Remote Code Execution Vulnerability in LabVIEW
CVE-2024-23609

7.8HIGH

Key Information:

Vendor

Ni

Status
Labview
Vendor
CVE Published:
11 March 2024

What is CVE-2024-23609?

An improper error handling vulnerability in LabVIEW can lead to significant security risks, including potential remote code execution. Malicious actors can exploit this flaw by crafting specially designed Virtual Instruments (VIs), which, when executed by the user, may trigger unauthorized actions within the target system. This vulnerability affects LabVIEW 2024 Q1 and earlier versions, emphasizing the need for users to apply available patches and updates from National Instruments to enhance their system security.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

LabVIEW Windows 0 <= 2024 Q1

References

https://www.ni.com/en/support/security/available-critical...

CVSS V3.1

Score:
7.8
Severity:
HIGH
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Local
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.